Wednesday, July 18, 2018
 
 
Company News: Page (1) of 1 - 10/17/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
New CDC Study Shows Many Healthcare Providers Reuse Syringes, Needles, and Single-Dose Vials for Multiple Patients
 
(October 17, 2017)
New CDC Study Shows Many Healthcare Providers Reuse Syringes, Needles, and Single-Dose Vials for Multiple Patients

A new study conducted by the Centers for Disease Control and Prevention (CDC) investigating the prevalence of reusing syringes, needles, and vials for multiple patients was recently published and brings to light some very important points about keeping patients safe. The study, published in the American Journal of Infection Control, surveyed both physicians and nurses to determine how often these practices are used.

Amazingly, over 12% of doctors and 3% of nurses responded stating that reuse of syringes for more than a single patient occurs where they work. Furthermore, 5% of doctors said that it occurred, "usually or always". In addition, the study showed that 25% of the physicians surveyed utilized single-dose vials for multiple patients, 29% used IV solution from a bag or bottle for more than one patient, and 43% reentered a multidose vial with the same syringe for an additional dose for the same patient.

It is clear that more work needs to be done to educate the medical community of the risks associated with these practices. For example, drawing multiple doses from a preservative-free single-dose vial can result in contaminated doses being administered to patients. Likewise, reentering a vial twice with the same syringe can easily contaminate the contents of the vial with blood-blood infections, such as Hepatitis B, Hepatitis C, and HIV.



Edge Pharmacy Services is a strong supporter of the One Needle, One Syringe, One Time Campaign. Edge works with hospitals, surgery centers, and private physician offices to help bring providers into compliance with CDC guidelines, as well as USP 797 regulations, for drawing and administering injections. To that end, Edge provides customers with premixed, unit-dose medications which alleviate these issues, making health care safer for both the patient, as well as the providers.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14719323.htm.


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Implantable Medical Devices Market Predicted to be Worth US$ 49.8 Bn by 2024, Says TMR
  • Global Cosmetic Chemicals Industry
  • HMP's 8th Annual Amputation Prevention Symposium Expected to Draw 800 Clinicians to Chicago to Join the CLI Revolution
  • Progressive Care Inc. Announces Month-End Sales Figures Showing Increase in Year-Over-Year Prescriptions Filled in June 2018

    Cancer
  • Camurus Announces PDUFA Date for CAM2038 for the Treatment of Opioid use Disorder
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally - QYResearch.com
  • Association of Community Cancer Centers and Advisory Board Launch 9th Annual Trends in Cancer Care Survey
  • Small Animal Imaging Market is Estimated to Grow at a Faster Pace With the Significant CAGR During the Forecast Period: Radiant Insights, Inc.
  • Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines